Tel Aviv Managing Shareholder Joey Shabot and Milan Co-Managing Partner Mario Santa Maria were featured on one of Italy’s most prominent newspapers, Italia Oggi. The article focuses on different aspects of Italian/Israeli business opportunities, with focus on new technologies based investments.
Santa Maria and Shabot offer a glance into government initiatives in both countries, that
GT’s cross-border team represents the Barinboim Group, an Israel-based private investment company, which has led a consortium of investors through a special purpose vehicle (SPV) that signed an agreement to acquire Finalto, Playtech’s financial trading division.
The acquisition, recently reported by different media outlets, is valued at $210 million. In addition to Barinboim, the SPV
,לורנס שטרנטל, שותף במחלקת הנדל”ן הבינלאומי במשרדנו בתל אביב
.מייצג את כלל ביטוח במסגרת עסקת נדל”ן גדולה בארה”ב
כפי שדווח ביום א’, 24 במאי, בכלכליסט, כלל ביטוח וענקית הביטוח האמריקאית מטלייף
.הקימו שותפות שתתמקד בהקמת נדל”ן בארה”ב
,כבר כעת, יצאו לדרך שלושה פרויקטים במסגרת השותפות
.בהם נבנים שטחי מסחר, יחידות דיור ואף
מה יתרונם של סטארטאפים מקומיים מול מקביליהם הזרים? אילו תעשיות צומחות בלב התקופה הנוכחית ואילו הזדמנויות חבויות בסקטורים החווים את הקשיים הרבים מכל?
מדוע יתכן וחברות הזנק ישראליות שנחשבות תמיד לאנדרדוג בקונטקסט העולמי, תהיינה אטרקטיביות יותר להשקעות בתקופה הקרובה? אילו מדינות מתחילות להראות סימנים של חזרה לשגרה בבחינת השקעות ולאילו נראה שייקח זמן ממושך יותר?
Congratulations to Riskified on their Series E funding round of $165 million! Greenberg Traurig is proud to have represented an institutional investor in this transaction, and excited to have been part of this incredible achievement.
For more details, please click here.
Tel Aviv Managing Shareholder Joey Shabot and Of-Counsel Ephraim Schmeidler recently represented a US-based family office as part of its investment into Israeli company Sight Diagnostics Ltd (Sight). Sight develops a platform for diagnosing blood diseases using computer vision technology and is a portfolio company of Clal Biotechnology Industries Ltd., traded on the Tel Aviv
On the eve of the new Jewish year, Maariv, one of Israel’s oldest and most respected publications, asked some leaders of the business community in Israel to share their most significant achievement from the past year. Among the eight people selected by Maariv was Gary M. Epstein, managing shareholder of Greenberg Traurig’s Tel Aviv office; co-chair of its Israel Practice; and senior chair of the firm’s Global Corporate & Securities Practice, who offered the readers a glance into the Tel Aviv office’s history, recent achievements, and goals for the future:
Continue Reading Oct. 2, 2016: Israeli Publication Maariv Sums-Up the Past Year with Israeli Business Leaders
On June 6, the Boston office of Greenberg Traurig hosted the Wharton Israel Conference “Spotlight on Israeli Innovation in Healthcare and Biopharmaceuticals” for Boston area biotechnology and pharmaceutical professionals with Israeli connections. Roman Fayerberg (Boston IP) gave the welcome remarks and Chinh H. Pham (Boston IP) moderated a discussion panel “From Idea to Implementation: A
Known to many as the “Start-up Nation,” Israel has also been dubbed “Silicon Wadi”; ranking 7th amongst all countries in venture capital activity outside of the U.S. In 2015 alone, there were 326 VC investments in Israel, approximately 60% of which were in the information technology sector. In a recent article entitled Inside Silicon
“…So a world-class chef and a Texan real estate investor walk into an Israeli bar.” Sound like the beginning of corny joke? Not quite. In February, team members from the recently completed “Texas Retail” deal gathered to celebrate the acquisition by Migdal and Menora, two of Israel’s largest financial institutions, of a significant interest in